<i>clec-4(ok2050)</i> and <i>clec-4(ya1)</i> decrease <i>C</i>. <i>elegans</i> feeding leading to a reduced bacterial load. by Barbara Pees (3313560)

Naringenin decreases mitochondrial function. by Lauren A. Eanes (20995499)

Decreased pulmonary cell inflammatory response in FI-A2 and G-A2 peptide vaccinated mice after RSV challenge. by Gertrud U. Rey (501694)

Genes whose expression was decreased in RASMC subjected to Na⁺,K⁺-ATPase inhibition. by Svetlana V. Koltsova (321381)

“…Given <i>in italics</i> are genes whose differential expression was detected in ischemic tissue by whole genome microarray-based analysis <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0110597#pone.0110597-Mazzatti1" target="_blank">[12]</a>–<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0110597#pone.0110597-Leonard1" target="_blank">[18]</a>. …”

The intracellular calcium chelator BAPTA decreased cell retention of I-HIV at 20 uM (panel A) and increased transport rate of I-HIV at 10 uM (panel B). by Shinya Dohgu (285633)

Transient VEP loss due to manipulation of the optic nerve. by Yeda Luo (710942)

Nanomolar Caffeic Acid Decreases Glucose Uptake and the Effects of High Glucose in Endothelial Cells by Lucia Natarelli (823310)

“…In HG, the presence of 10 nM caffeic acid was associated with a decrease of glucose uptake but not to changes of GLUT-1 membrane localization or mRNA levels. …”

Simvastatin administration to mice decreased prenylation of specific small G proteins, as measured by a decrease in their membrane association. by Stephen R. Spindler (183870)

A Y45F mutation in hepatitis C virus NS4A causes a decrease in infectious viral titer. by Allison E. Roder (6312761)

Neurite length in <i>Thap1</i>^<i>+/-</i> and <i>Thap1</i>^{<i>C54Y/+</i>} E16 primary striatal neurons <i>in vitro</i> is decreased relative to neurons from WT m... by Zuchra Zakirova (431614)

Data_Sheet_1_Concurrent use of statins decreases major bleeding and intracerebral hemorrhage in non-valvular atrial fibrillation patients taking direct oral anticoagulants—A nation... by Hsin-Hsu Wu (440386)

“…</p>Results<p>50,854 (56.0%) of them were male with a mean age of 74.9 (SD, 10.4) years. …”

Results of peptide toxicity of each diet. by Fatima Dikhanbayeva (11501962)

“…<p>Values are given as mean ± SD for a total of 50 animals. Control group (I) - 0.295 nm, Curd mass (II)– 0.122 nm, Curd mass with flaxseed flour (III)– 0.113 nm, curd mass with celery root powder (IV) - 0.114 nm, Curd mass with bee bread (V)– 0.127 nm. …”

Comparison of physiological and perceptual measures of national-level rowing athletes taken during a 10-min submaximal rowing test performed at 95% of 30-min time-trial average pow... by Calvin P. Philp (12095878)

KLF4 knockdown decreased the population of cancer stem cells and cell migration in A431 cells. by Juan Li (146180)

The results of assay of blood serum biochemical parameters after experiment. by Fatima Dikhanbayeva (11501962)

“…*Values are given as mean ± SD for a total of 50 animals. p<0, 05 versus mice fed regular diet.…”

Decreased tumorigenicity of A549 cells <i>in vivo</i> with reduced IQGAP3 expression. by Ying Yang (24175)

APAP bioactivation is decreased in fructose-fed mice. by Sungjoon Cho (4385851)

Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor by Beatrice Noce (16540800)

“…We found that <b>9a</b>, bearing a pargyline moiety, is also able to selectively inhibit MAOB over MAOA (465-fold) with an IC₅₀ of 0.182 μM, being the first-in-class dual NOX2/MAOB covalent inhibitor. …”

Patterns of disease knowledge according to number of participants giving correct answers to each individual Chinese IBD-KID2 item, with vertical line representing 50% of the overal... by HaiQun Huang (20978503)

Discovery of Triazolyl Derivatives of Cucurbitacin B Targeting IGF2BP1 against Non-Small Cell Lung Cancer by Fan-Fan Shang (16953264)

“…Among them, derivative <b>A11</b> had the most potent antiproliferative activity against A549 lung cancer cells (IC₅₀ = 0.009 μM) and was approximately 10-fold more potent than CuB, while the cytotoxicity of <b>A11</b> toward normal L02 cells was about 10-fold less potent, indicating a much wider therapeutic window than CuB. …”